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Abstract
Background: Characterising the overlap of C. difficile genotypes in different reservoirs can improve our
understanding of possible transmission routes of this pathogen. Most of the studies have focused on a comparison
of the PCR ribotype 078 isolated from humans and animals. Here we describe for the first time a comparison of
C. difficile genotypes isolated during longer time intervals from different sources including humans, animals and the
non-hospital environment.
Results: Altogether 786 isolates from time interval 2008-2010 were grouped into 90 PCR ribotypes and eleven of
them were shared among all host types and the environment. Ribotypes that were most common in humans
were also present in water and different animals (014/020, 002, 029). Interestingly, non-toxigenic isolates were very
common in the environment (30.8%) in comparison to humans (6.5%) and animals (7.7%). A high degree of
similarity was observed for human and animal isolates with PFGE. In human isolates resistance to erithromycin,
clindamycin and moxifloxacin was detected, while all animal isolates were susceptible to all antibiotics tested.
Conclusion: Our results show that many other types in addition to PCR Ribotype 078 are shared between humans
and animals and that the most prevalent genotypes in humans have the ability to survive also in the environment
and several animal hosts. The genetic relatedness observed with PFGE suggests that transmission of given
genotype from one reservoir to the other is likely to occur.
Background
Intestinal diseases caused by Clostridium difficile, mainly
after antibiotic treatment, ranges from mild self-limiting
diarrhoea to life-threatening pseudomembranous colitis
(PMC) and were until recently most commonly seen in
hospitalized elderly patients [1]. However, the incidence
of community-onset C. difficile infection has increased
[2-4] and C. difficile has also emerged as a pathogen or
commensal in different animals such as pigs, calves and
chickens [5-7]. Studies on C. difficile in the environment
are sparse and describe its presence in soil and water
[8-11]. For both, environmental contamination and com-
munity-associated human infections, animals have been
suggested as possible reservoir [5,12,13].
The most prevalent PCR ribotypes differ between
humans and food animals. In bovine and porcine hosts
PCR ribotype 078 (corresponding to NAP7 and NAP8 by
PFGE) is most often detected [14-16]. In humans
approximately 300 PCR ribotypes are recognized and the
most prevalent in many European countries is PCR ribo-
type 014/020 (toxinotype 0) [17]. However, in both ani-
mals and humans, the distribution of ribotypes is
different between countries and from setting to setting,
although the heterogeneity is much lower in animals
compared to humans. Two large pan-European studies
have shown these geographic differences for human-
associated C. difficile [17,18]. Commonly identified PCR
ribotypes for which only regional spreading is suggested
are 106, the predominant strain in the UK, ribotype 053
in Austria and 018 which is predominant in Italy [19,20].
In the United States and Canada NAP1, corresponding to
PCR ribotype 027 is one of the predominant strains in
humans, and in Japan and Korea PCR ribotype 017/toxi-
notype VIII (A-B+) strain is responsible for CDI
outbreaks [21,22].
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types in humans and food animals have focused on ribo-
type 078 strain comparisons [23-25]. In addition to being
the most frequently isolated strain from pigs and calves
in North America and the Netherlands [14-16] it is
becoming prevalent in humans in hospitals [17,26] and in
the community [3]. It is also often the most prevalent
ribotype isolated from food [13,27]. Some other currently
important human ribotypes (027, 017) are also reported
from animals, [5] but they seem to be less well estab-
lished in animal hosts. There is currently no published
report comparing a large number of strains isolated in
t h es a m eg e o g r a p h i cr e g i o nf r o md i f f e r e n ts o u r c e s ,
including humans, animals and the environment. This
study makes such a comparison of C. difficile strains iso-
lated from three of the possible main reservoirs in a sin-
gle country to show that ribotypes other than 078 are
shared between host types and the environment.
Results and discussion
Distribution of PCR ribotypes in different hosts and the
environment
All 786 isolates that were isolated between 2008 and 2010
were grouped into 90 different PCR ribotypes; human
isolates into 77 ribotypes, animal isolates into 23 ribo-
types and the environmental isolates into 36 ribotypes
(Figure 1, see also Additional file 1: Table S1). There was
a considerable overlap between C. difficile ribotypes iso-
lated from humans, animals and the environment. Eleven
PCR ribotypes were common to all three reservoirs. Six-
teen PCR ribotypes were shared only between humans
and the environment and were not found in animals, and
eight PCR ribotypes were common only to humans and
animals. None of the PCR ribotypes identified was shared
just between animals and the environment. These results
agree in part with previous observations that most geno-
types present in animals are also isolated from humans in
the same region [15,16,28]. Only a single study compared
environmental and human C. difficile isolates and also
noticed an overlap as 17 of 23 PCR ribotypes were shared
between human and environmental strains [9].
The distribution of the most common PCR ribotypes
isolated from all three reservoirs in the time period from
2008 to 2010 is shown in Table 1. Interestingly, 30.8% of
the environmental isolates were non-toxigenic compared
to only 6.5% of human and 7.7% of animal isolates (P <
0.0001; Fisher’s exact test). When only toxigenic strains
are compared, the two most prevalent PCR ribotypes
shared between all three reservoirs were 014/020 and 002
accounting for 20.1% and 8.2% (humans), 24.0% and
23.1% (animals), and 19.8% and 6.2% (environment),
respectively. Results for PCR ribotypes 014 and 020 are
combined as these two ribotypes have very similar band-
ing pattern which is sometime difficult to distinguish
using classical agarose gel-based electrophoresis. Ribo-
types 014/020 and 002 are also among the most prevalent
ribotypes in Europe [17]. This suggests that ability to sur-
vive in different environments plays a role in successful
distribution and a high prevalence of a given genotype.
As already mentioned, most publications dealing with
comparisons of animal and human strains focus on por-
cine ribotype 078 strains and suggest that pig farms can
be an important emerging source of human infection or
colonization [23,24]. Our previous studies have shown
that ribotype 078 can be completely absent in animals in
a given country and that ribotypes other than PCR ribo-
type 078 (toxinotype V) are prevalent in pigs and other
farm animals in Slovenia [7,29,30]. PCR ribotype 078
(toxinotype V) has been found only in humans in Slove-
nia; of six isolates identified, five came from stool speci-
mens and one from an infected wound. PCR ribotype
126 (toxinotype V and highly related to ribotype 078) has
been found in humans (7 isolates) and rivers (1 isolate).
Current epidemic strain, PCR ribotype 027/toxinoty-
peIII/NAP1 was reported in domestic animals and their
environment mostly in Canadian studies [16,31,32]. Our
collection did not include any animal 027 strain. First
human PCR ribotype 027 strain was identified only in
2010 and this type accounted for as little as 2.7% (16/601)
of all human isolates (see Additional file 1: Table S1).
Characterisation of most common PCR ribotypes found in
animals and humans
D u et ot h el a r g en u m b e ro fi s o l a t e sa v a i l a b l e( n=1 0 7 8 )
o n l yas u b s e to fr e p r e s e n t a t i v es t r a i n sf r o mt h em o s t
common PCR ribotypes found in humans and animals
were further characterized with PFGE and antimicrobial
susceptibility testing. Selected strains belonged to 7 dif-
ferent PCR ribotypes: 014/020/(toxinotype 0), 010/(non-
toxigenic strain; tox-), SLO 055/(tox-), 023/(toxinotype
IV), 029/(toxinotype 0), 002/(toxinotype 0) and 150/(toxi-
notype 0). A single strain of PCR ribotype SLO 055 was
included in the comparison as its PCR ribotyping profile
is very similar to the profile of PCR ribotype 010.
The majority of strains of a single PCR ribotype iso-
lated from humans and animals grouped together with
PFGE regardless of which restriction enzyme was used
(SmaIo rSacII). With SmaIg r o u p sw e r em o r ec o h e r e n t
and in four toxigenic PCR ribotypes (002, 029, 014/020
and 023), human and animal isolates had indistinguish-
able banding pattern (groups 2-5 on the Figure 2). How-
ever, when restriction was performed with SacII, only
one pig isolate had an identical banding pattern to the
human one while other animal isolates differed from
human isolates of the same ribotype but still belonged to
the same pulsotype (defined by 80% and 85% similarity
for SmaIa n dSacII, respectively). Within non-toxigenic
group of strains (group 1 on the Figure 2) a human
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Page 2 of 8isolate of PCR ribotype SLO 055 (related to ribotype 010)
had an identical banding pattern when restriction was
performed with SmaI, though with SacII the human and
the two animal isolates belonged to different pulsotypes.
These results are in agreement with previous studies
reporting human and food animal strains to be very clo-
sely related or indistinguishable using different typing
methods. In the USA toxinotype V strains (PFGE type
NAP7/NAP8 corresponding to ribotype 078) isolated
from humans and pigs have been found to be indistin-
guishable with PFGE [25]. In more recent study by
Koene et al. (2011), comparing human and animal iso-
lates from the same geographic location and time period
with the MLVA, authors confirmed previously observed
relatedness between human and porcine ribotype 078
strains but in contrast to our PFGE results (group 4 on
Figure 2) no genetic relatedness could be observed for
human and animal isolates of ribotype 014 and 012
[24,33].
A great focus has been given on pigs as a source of
human CDI. Poultry which can harbour a variety of
human associated PCR ribotypes has been so far
overlooked [7]. Two human and one poultry isolate of
ribotype 023 (toxinotype IV, binary toxin positive) had
indistinguishable banding pattern with SmaI and belonged
to the same pulsotype with SacII (group 5 on Figure 2).
For companion animals (dogs and cats) has also been
shown to harbour the same ribotypes as humans [15,33].
In our study, one dog and one cat isolate of PCR ribotype
014/020 had identical banding pattern as the human iso-
lates of the same PCR ribotype using SmaI restriction
enzyme and belonged to the same pulsotype when SacII
restriction patterns were compared (group 4 on Figure 2).
The genetic relatedness of human and animal isolates
shown in this study suggests that not only ribotype 078
strains show zoonotic potential. Other ribotypes are
shared between animals and humans as well, and that
alongside porcine and cattle, poultry can also be an
important link for human CDI. Whether and how often
the transmission from animals to humans and/or vice
versa occurs have yet to be determined.
Table 2 lists the range of MICs of the most common
PCR ribotypes isolated from humans and animals for five
out of six antibiotics tested. All isolates tested were fully
Humans Humans
(n=77)
42
8 8
11 11
16 16
9 94
0 0
Animals
(n=23)
Environment
(water/soil)
(n=36) (n 36)
Figure 1 Comparison of distribution of ribotypes from different reservoirs.
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strains within a single PCR ribotype had similar but not
identical MICs for all antibiotics tested. Exceptions
include high MICs to erythromycin (ERY), clindamycin
(CLI) and moxifloxacin (MXF) (Table 2, Figure 2) for
human ribotype 014/020 strains. Interestingly, all three
human ribotype 010 strains (all non-toxigenic) had MICs
≥ 256 mg/ml for CLI and ERY (2 isolates), and CLI plus
MXF (1 isolate). This multiple drug resistance in non-
toxigenic strains could suggest that these strains might
serve as reservoir of antibiotic resistance determinants.
Strains resistant to the antibiotics tested were found only
among human isolates. However, only for moxifloxacin,
MICs for human isolates were more likely to be above
the MIC50 of all isolates tested (P < 0.05) (Table 3).
Conclusions
Ribotype 078 is not the only ribotype significantly shared
between humans and animals. Here we show that all gen-
otypes that are among most prevalent in (hospitalized)
humans have a tendency to prevail also in animals and in
the environment (river water) and that a better environ-
mental survival might be part of their virulence spectrum.
Human and animal isolates of the same PCR ribotype
clustered together with PFGE and had mostly also similar
MIC values for all antibiotics tested. This genetic
relatedness suggests that transmission of given genotype
from one reservoir to the other is likely to occur.
Materials and methods
C. difficile isolates
Isolates included in the comparison originated from
humans, animals and the non-hospital environment and
are part of the strain collection at the Institute of Public
Health Maribor. Altogether 1078 isolates from Slovenia
were available. Isolates from all three reservoirs were
sampled from the overlapping geographical locations and
time periods.
Human isolates (n = 690) were recovered by routine
diagnostic laboratories throughout Slovenia and sub-
mitted to our laboratory for typing between 2006 and
2010. The isolates were from hospitalized patients and
from patient from other institutions (less than 1% of all
isolates), and were not submitted as a part of an out-
break investigation.
Environmental isolates were from river water (n = 77)
and soil (n = 4), and were isolated between 2008 and 2010.
River water isolates from 17 rivers throughout Slovenia
were collected as a part of the national surveillance of sur-
face waters. Soil isolates originated from the field near the
poultry farm from which poultry samples were collected.
The isolates were cultured as described elsewhere [11].
Animal isolates (n = 307) were from piglets (n = 138),
calves (n = 6), a horse (n = 1), poultry and birds (n =
150), and dogs and cats (n = 12) isolated between 2006
and 2010. Piglet isolates (including symptomatic and
asymptomatic animals) were from 9 pig farms located in
different parts of Slovenia. Poultry isolates were from
two big facility for laying hens and three smaller farms.
Dog, cat and calf isolates were from different Slovenian
households and farms. Stool samples or rectal swabs
collected from these animals were processed as
described elsewhere [7,29]. Due to the clustering (i.e.
large number of isolates from the same animal farm),
only 156 animal isolates (piglets (n = 16), poultry and
birds (n = 121), dogs and cats (n = 12), calves (n = 6)
and a horse) were included in the final analysis (only a
single strain isolated per sampling and per farm).
The final number of isolates included in the compari-
son of prevalence and distribution of PCR ribotypes was
786 (601 from human, 104 from animals and 81 from
the environment) from the time period 2008-10, as for
this time period environmental strains were available.
For the PFGE and antimicrobial susceptibility testing of
human and animal strains, 50 isolates from broader
time interval (2006-2010) were selected.
Molecular characterisation
All isolates were characterised by toxinotyping and PCR
ribotyping. Toxinotyping involved amplification and
Table 1 Most prevalent PCR ribotypes in humans,
animals and the environment isolated between 2008 and
2010
PCR ribotype/toxinotype Humans
(n = 601)
Animals
(n = 104)
Environment
(n = 81)
014/020/0 or I 121 (20.1%) 25 (24.0%) 16 (19.8%)
002/0 49 (8.2%) 24 (23.1%) 5 (6.2%)
001/072/0, tox- or XXIV (CDT+)
§ 42 (7.0%) 8 (7.7%) 2 (2.5%)
012/0 30 (5.0%) /* 1 (1.2%)
023/IV (CDT+) 30 (5.0%) /* 3 (3.7%)
018/0 27 (4.5%) / 2 (2.5%)
029/0 24 (4.0%) 1 (1.0%) 3 (3.7%)
150/0 15 (2.5%) 9 (8.7%) /
SLO 080/tox- 1 (0.2%) 7 (6.7%) 1 (1.2%)
045/V (CDT+) 1 (0.2%) 5 (4.8%) /
010/tox- 14 (2.3%) /* 9 (11.1%)
SLO 057/tox- 1 (0.2%) / 4 (4.9%)
SLO 064/tox- 2 (0.3%) / 4 (4.9%)
078/V 6 (1.0%) / /
126/V 6 (1.0%) / 1 (1.2%)
PCR ribotypes marked with* have been found in animals only not between
years 2008-10.
§Results for PCR ribotypes 001 and 072 are combined in this
table since they have a very similar banding pattern which is sometime
difficult to distinguish using classical agarose gel-based electrophoresis.
Ribotypes 078 and 126 are not among the most prevalent ribotypes and are
added only for comparison. (CDT +) - binary toxin positive
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Page 4 of 8Figure 2 PFGE dendrogram of SacII restriction digest. PFGE dendrogram (SacII restriction digest) and the association with PFGE patterns of
SmaI restriction digest, toxinotype, PCR ribotype, origin and antibiotic susceptibility testing. The dendrogram is coded according to origin;
human isolates (*) and animal isolates (■). The MICs are given in terms of mg/L. The bars represent the groups (1-5) of human and animal
isolates having identical SmaI and/or SacII banding pattern.
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tcdA) and B1 (part of tcdB). PaLoc negative strains were
confirmed by amplification of a 115 bp-long insert with
primers Lok1/Lok3 [34]. The binary toxin gene (cdtB)
was detected as described previously [35].
PCR ribotyping was performed with the primers 16S
(5’-GTGCGGCTGGATCACCTCCT) and 23S (5’-CCCT
GCACCCTTAATAACTTGACC) as described by Bidet
et al. (1999) [36]. After amplification PCR products were
concentrated to a final volume of 25 μlb yh e a t i n ga t
75°C for 45 min before electrophoresis in 3% agarose gel
(Bio-Rad, USA) in 1× TAE buffer for 5 h at 2.5 V/cm.
BioNumerics software (Applied Maths, Belgium) version
6.10 was used to analyze the banding patterns. PCR ribo-
types for which reference strains were available were
designated by standard Cardiff nomenclature (002, 029...;
46 Cardiff type strains were available in our laboratory
for comparisons) while others were designated by inter-
nal nomenclature (SLO and 3-digit code).
At o t a lo f5 0C. difficile isolates of the most prevalent
PCR ribotypes found in humans and animals isolated
between 2006 and 2010 were further analyzed with PFGE
and antimicrobial susceptibility testing. Selection of the
strains was made by randomly selecting human and ani-
mal strains isolated in the same time period and from the
same geographic locations covering different Slovenian
regions. These included 32 human isolates and 18 animal
isolates from pigs (n = 3), poultry (n = 8), a cat (n = 1),
calves (n = 2) and dogs (n = 4).
Pulsed field gel electrophoresis
PFGE was performed as described elsewhere [37]. Geno-
mic DNA was digested with 15 U of SacII or SmaI( N e w
England BioLabs, UK) overnight and Biometra PFGE Sys-
tem (Biometra, Germany) was used for electrophoresis.
Dendrograms were constructed using BioNumerics soft-
ware 6.10 (Applied Maths, Belgium) by the UPGMA
clustering method, using the Dice coefficient with posi-
tion tolerance and optimization of 1.10%. Clusters with ≥
80% (SmaI) or ≥ 85% (SacII) similarity were considered
to be distinct pulsotypes.
Antimicrobial susceptibility testing
The same strains typed by PFGE were also tested for anti-
biotic resistance. Minimum inhibitory concentrations
(MICs) of 6 antimicrobial agents; rifampicin (RIF), moxi-
floxacin (MXF), erythromycin (ERY), piperacilin/tazobac-
tam (TZP), tetracycline (TET) and clindamycin CLI), were
determined by the E-test method. An inoculum of McFar-
land 1.0 was swabbed on Brucella blood agar supplemen-
ted with haemin (5 μg/mL) and vitamin K1 (1 μg/ml).
Plates were incubated for 48 h at 37°C in an anaerobic
atmosphere. Bacteroides thetaiotaomicron ATCC 29741
was used as a quality control strain. Resistance was defined
Table 2 MIC ranges of most common PCR ribotypes isolated from humans and animals
PCR ribotype ERY
(mg/L)
MXF
(mg/L)
TET
(mg/L)
CLI
(mg/L)
TZP
(mg/L)
002 (n = 11) 0.5-3 0.75-1.5 0.032-0.19 0.125-8 3-8
023 (n = 7) 0.5-1.5 0.19-1 0.047-0.094 0.023-3 4-8
029 (n = 4) 0.75-2 0.5-1 0.047-0.125 1.5-4 3-12
014/020 (n = 18) 0.38- > 256 0.38- > 256 0.025-0.19 1.5- > 256 1.5-16
010 (n = 6) 0.38- > 256 0.75- > 256 0.064-1.5 1- > 256 1.5-64
150 (n = 3) 1.5-2 0.75-1 4-8 3-8 4-8
ERY - erythromycin; CLI - clindamycin; TET- tetracycline; TZP - piperacillin/tazobactam; MXF - moxifloxacin; Ribotype SLO 055 (n = 1) is not included in this table,
but is included in Table 3
Table 3 MIC50/90 values of human and animal C.difficile isolates
Host ERY
(mg/L)
MXF
(mg/L)
TET
(mg/L)
CLI
(mg/L)
TZP
(mg/L)
Humans (n = 32) MIC50 1.5 1 0.094 3 6
MIC90 3 > 256 0.19 > 256 12
Range 0.38- > 256 0.50- > 256 0.025-8 1- > 256 1.5-64
Animals (n = 18) MIC50 1 0.75 0.125 3 6
MIC90 2 1 0.19 5 8
Range 0.38-3 0.19-1 0.047-4 0.023-6 1.5-16
All (n = 50) MIC50 1.5 1 0.094 3 6
MIC90 3 1.5 0,19 8 8
Range 0.38- > 256 0.19- > 256 0.025-8 0.023- > 256 1.5-64
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CLSI guidelines: clindamycin (CLI) ≥ 8 mg/l, tetracycline
(TET) ≥ 16 mg/l, piperacillin/tazobactam (TZP) ≥
128 mg/l, moxifloxacin (MXF) ≥ 8 mg/l, erythromycin
(ERY) ≥ 8 mg/l and rifampicin (RIF) ≥ 4 mg/l [38,39].
MIC50 and MIC90 were calculated for human and animal
isolates. The frequencies at which the MICs for human
isolates were above the MIC50 and MIC90 values for all
isolates tested were compared with Fisher’se x a c tt test.
Additional material
Additional file 1: Table S1. PCR ribotypes identified in humans, animals
and the environment between 2008 and 2010 in Slovenia.
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